Switch to:
Chemocentryx Inc (NAS:CCXI)
EV/EBIT
8.50 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Chemocentryx Inc's enterprise value is $93.55 Mil. Chemocentryx Inc's operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $-39.12 Mil. Therefore, Chemocentryx Inc's EV/EBIT ratio for today is 8.50.

CCXI' s 10-Year EV/EBIT Range
Min: 46.6   Max: 97
Current: 8.5

46.6
97

During the past 5 years, the highest EV/EBIT Ratio of Chemocentryx Inc was 97.00. The lowest was 46.60. And the median was 54.20.

CCXI's EV/EBITis ranked higher than
82% of the 468 Companies
in the Global Biotechnology industry.

( Industry Median: 20.00 vs. CCXI: 8.50 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Chemocentryx Inc's enterprise value for the quarter that ended in Dec. 2013 was $114.92 Mil. Chemocentryx Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $-39.12 Mil. Chemocentryx Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 0.00%.


Definition

Chemocentryx Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=93.545/-39.115
=

Chemocentryx Inc's current Enterprise Value is $93.55 Mil.
Chemocentryx Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -10.292 (Mar. 2013 ) + -9.599 (Jun. 2013 ) + -9.553 (Sep. 2013 ) + -9.671 (Dec. 2013 ) = $-39.12 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Chemocentryx Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=-39.115/114.9203
= %

Chemocentryx Inc's Enterprise Value for the quarter that ended in Dec. 2013 was $114.92 Mil.
Chemocentryx Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -10.292 (Mar. 2013 ) + -9.599 (Jun. 2013 ) + -9.553 (Sep. 2013 ) + -9.671 (Dec. 2013 ) = $-39.12 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Chemocentryx Inc Annual Data

Dec09Dec10Dec11Dec12Dec13
ev2ebit 0.000.000.000.000.000.000.000.000.000.00

Chemocentryx Inc Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 0.000.00144.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide